Overlapping and interactive pathways regulating appetite and craving

Journal of Addictive Diseases

Volumn 23, Issue 3, 2004, Pages 5-21

  Kalra, Satya P ^a   Kalra, Pushpa S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Addiction; Appetite; Circuitry; Craving; Endocannabinoids; Ethanol; Ghrelin; Hormones; Hypothalamus; Leptin; Neuropeptide Y; Nicotine; Opiates

Indexed keywords

ALCOHOL; CANNABINOID; GHRELIN; LEPTIN; NEUROPEPTIDE Y; NEUROTRANSMITTER; NICOTINE; OPIATE;

ANTERIOR HYPOTHALAMUS; APPETITE; ARCUATE NUCLEUS; DRIVE; DRUG ABUSE; FEEDBACK SYSTEM; HOMEOSTASIS; HYPOTHALAMUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STOMACH; WHITE ADIPOSE TISSUE; WITHDRAWAL SYNDROME;

ADIPOSE TISSUE; APPETITE REGULATION; BODY WEIGHT; ENDOCANNABINOIDS; ENERGY INTAKE; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; NARCOTICS; NEUROPEPTIDES; NICOTINE; PEPTIDE HORMONES; SIGNAL TRANSDUCTION; STOMACH; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 3843149632     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v23n03_02     Document Type: Review

References (83)

1. Bray GA. Historical framework for the development of ideas about obesity. In: Handbook of Obesity, Marcel DeKer, Inc., ed., New York: 1998:1-29.
2. Kalra SP, Dube MG, Pu S, et al. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev. 1999;20:68-100.
3. Anand BK, Brobeck JR. Hypothalamic control of food intake in rats and cats. The Yale Journal of Biology and Medicine. 1951;24:123-146.
4. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 1984;115:427-429.
5. Kalra SP, Clark JT, Sahu A, et al. Control of feeding and sexual behaviors by neuropeptide Y: Physiological implications. Synapse. 1988;2:254-257.
6. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763-770.
7. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660.
8. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908-913.
9. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194-198.
10. Kalra SP, Bagnasco M, Otukonyong EE, et al. Rhythmic, reciprocal ghrelin and leptin signaling: New insight in the development of obesity. Regul Pept. 2003;111:1-11.
11. Tartar RE, Ammerman RT, Ott PJ. Handbook of substance abuse. In: Neurobehavioral Pharmacology. Tartar RE, Ammerman RT, Ott PJ eds. New York: Premum Press, 1998.
12. Kalivas PW, Samson HH. The Neurobiology of drug and alcohol addiction. Ann N Y Acad Sci. 1992;654:1-545.
13. Imura H, Kato Y, Nakai Y, et al. Endogenous opioids and related peptides: From molecular biology to clinical medicine. The Sir Henry Dale lecture for 1985. J Endocrinol. 1985;107:147-157.
14. Morley JE. Neuropeptide regulation of appetite and weight. Endocr Rev. 1987;8:256-287.
15. Horvath TL, Naftolin F, Kalra SP, Leranth C. Neuropeptide-Y innervation of beta-endorphin-containing cells in the rat mediobasal hypothalamus: A light and electron microscopic double immunostaining analysis. Endocrinology. 1992;131:2461-2467.
16. Karch SB. Pathology of Drug Abuse. CRC Press LLC, Boca Raton, FL 2002, pp. 1-537.
17. De Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci. 1998;95:322-327.
18. Dube MG, Kalra SP, Kalra PS. Food intake elicited by central administration of orexins/hypocretins: Identification of hypothalamic sites of action. Brain Res. 1999;842:473-477.
19. Qu D, Ludwig DS, Gammeltoft S, et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature. 1996;380:243-247.
20. Bagnasco M, Dube MG, Kalra PS, Kalra SP. Evidence for the existence of distinct central appetite and energy expenditure pathways and stimulation of ghrelin as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology. 2002;143:4409-4421.
21. Kalra SP, Kalra PS. Nutritional infertility: The role of the interconnected hypothalamic neuropeptide Y-galanin-opioid network. Front Neuroendocrinol. 1996;17:371-401.
22. Kalra SP, Dube MG, Sahu A, et al. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci. 1991;88:10931-10935.
23. Kalra PS, Dube MG, Xu B, Kalra SP. Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain. Regul Pept. 1997;72:121-130.
24. Pu S, Jain MR, Horvath TL, et al. Interactions between neuropeptide Y and gamma-aminobutyric acid in stimulation of feeding: A morphological and pharmacological analysis. Endocrinology. 1999;140:933-940.
25. Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411:480-484.
26. Ollmann MM, Wilson BD, Yang YK, et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 1997;278:135-138.
27. Hahn TM, Breininger JF, Baskin DG, Schwartz MW. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci. 1998;1:271-272.
28. Broberger C, Hokfelt T. Hypothalamic and vagal neuropeptide circuitries regulating food intake. Physiol Behav. 2001;74:669-682.
29. Smith MS, Grove KL. Integration of the regulation of reproductive function and energy balance: Lactation as a model. Front Neuroendocrinol. 2002;23:225-256.
30. Jain MR, Horvath TL, Kalra PS, Kalra SP. Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats. Regul Pept. 2000;87:19-24.
31. Dube MG, Horvath TL, Kalra PS, Kalra SP. Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in sated rats. Peptides. 2000;21:1557-1560.
32. Chaffer CL, Morris MJ. The feeding response to melanin-concentrating hormone is attenuated by antagonism of the NPY Y(1)-receptor in the rat. Endocrinology. 2002;143:191-197.
33. Horvath TL, Diano S, van den Pol AN. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations. J Neurosci. 1999;19:1072-1087.
34. Elias CF, Saper CB, Maratos-Flier E, et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol. 1998;402:442-459.
35. Saper CB, Chou TC, Elmquist JK. The need to feed: Homeostatic and hedonic control of eating. Neuron. 2002;36:199-211.
36. Schwartz MW, Woods SC, Porte D, et al. Central nervous system control of food intake. Nature. 2000;404:661-671.
37. Horvath TL, Diano S, Sotonyi P, et al. Minireview: Ghrelin and the regulation of energy balance - A hypothalamic perspective. Endocrinology. 2001;142:4163-4169.
38. Morash B, Li A, Murphy PR, et al. Leptin gene expression in the brain and pituitary gland. Endocrinology. 1999;140:5995-5998.
39. Bagnasco M, Kalra PS, Kalra SP. Ghrelin and leptin pulse discharge in fed and fasted rats. Endocrinology. 2002;143:726-729.
40. Beretta E, Dube MG, Kalra PS, Kalra SP. Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: Effects on serum ghrelin and appetite-regulating genes. Ped. Res. 2002;52:189-198.
41. Dube MG, Beretta E, Dhillon H, et al. Central leptin gene therapy blocks high fat diet-induced weight gain, hyperleptinemia and hyperinsulinemia: Effects on serum ghrelin levels. Diabetes. 2002;51:1729-1736.
42. Ueno N, Dube MG, Katz A, et al. Leptin inhibits ghrelin-induced obesity by two distinct central and peripheral mechanisms: Effects on adiponectin, 33rd Annual Society for Neuroscience Meeting, New Orleans, LA, November 2003.
43. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-295.
44. Pu S, Dube MG, Kalra PS, Kalra SP. Regulation of leptin secretion: Effects of aging on daily patterns of serum leptin and food consumption. Regul Pept. 2000;92:107-111.
45. Dhillon H, Kalra SP, Prima V, et al. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: A long-term study. Regul Pept. 2001;99:69-77.
46. Kalra PS, Kalra SP. Obesity and metabolic syndrome: Long-term benefits of central leptin gene therapy. In: Prous, JR Ed. Drugs of Today. Barcelona, Spain: Prous Science, 2002;38:745-757.
47. Kalra SP. Circumventing leptin resistance for weight control. Proc Natl Acad Sci. 2001;98:4279-4281.
48. Wise RA. Brain reward circuitry: Insights from unsensed incentives. Neuron. 2002;36:229-240.
49. Holderness CC, Brooks-Gunn J, Warren MP. Co-morbidity of eating disorders and substance abuse review of the literature. Int J Eat Disord. 1994;16:1-34.
50. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97-129.
51. Thiele TE, Marsh DJ, Ste Marie L, et al. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature. 1998;396:366-369.
52. Ehlers CL, Li TK, Lumeng L, et al. Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. Alcohol Clin Exp Res. 1998;22:1778-1782.
53. Hwang BH, Zhang JK, Ehlers CL, et al. Innate differences of neuropeptide Y (NPY) in hypothalamic nuclei and central nucleus of the amygdala between selectively bred rats with high and low alcohol preference. Alcohol Clin Exp Res. 1999;23:1023-1030.
54. Clark JT, Keaton AK, Sahu A, et al. Neuropeptide Y (NPY) levels in alcoholic and food restricted male rats: Implications for site selective function. Regul Pept. 1998;75-76:335-345.
55. Kelley SP, Nannini MA, Bratt AM, Hodge CW. Neuropeptide-Y in the paraventricular nucleus increases ethanol self-dministration. Peptides. 2001;22:515-522.
56. Woldbye DP, Ulrichsen J, Haugbol S, Bolwig TG. Ethanol withdrawal in rats is attenuated by intracerebroventricular administration of neuropeptide Y. Alcohol. 2002;37:318-321.
57. Thiele TE, Koh MT, Pedrazzini T. Voluntary alcohol consumption is controlled via the l neuropeptide Y Y1 receptor. J Neurosci. 2002;22:RC208.
58. Okubo T, Harada S. Polymorphism of the neuropeptide Y gene: An association study with alcohol withdrawal. Alcohol Clin Exp Res. 2001;25:59S-62S.
59. Fulton S, Woodside B, Shizgal P. Modulation of brain reward circuitry by leptin. Science. 2000;287:125-128.
60. Kiefer F, Jahn H, Kellner M, et al. Leptin as a possible modulator of craving for alcohol. Arch Gen Psychiatry. 2001;58:509-510.
61. Obradovic T, Meadows GG. Chronic ethanol consumption increases plasma leptin levels and alters leptin receptors in the hypothalamus and the perigonadal fat of C57BL/6 mice. Alcohol Clin Exp Res. 2002;26:255-262.
62. Fride E. Endocannabinoids in the central nervous system - an overview. Prostaglandins Leukot Essent Fatty Acids. 2002;66:221-233.
63. Williams CM, Kirkham TC. Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav. 2002;71:333-340.
64. Williams CM, Kirkham TC. Observational analysis of feeding induced by Delta 9-THC and anandamide. Physiol Behav. 2002;76:241-250.
65. Williams CM, Kirkham TC. Anadamide induces overeating: Mediation by central cannabinoid (CBI) receptors. Psychopharmacology. 1999;143:315-317.
66. Di Marzo V, Goparaju SK, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 2001;410:822-825.
67. Kirkham TC, Williams CM, Fezza F, DiMarzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: Stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol. 2002;136:550-557.
68. Jamshidi N, Taylor DA. Anadamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol. 2001;134:1151-1154.
69. Albanes D, Jones DY, Micozzi MS, Mattson ME. Associations between smoking and body weight in the US population: Analysis of NHANES II. Am J Public Health. 1987;77:439-444.
70. O'Hara P, Connett JE, Lee WW, et al. Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol. 1998;148:821-830.
71. Li MD, Kane JK, Parker SL, et al. Nicotine administration enhances NPY expression in the rat hypothalamus. Brain Res. 2000;867:157-164.
72. Lupien JR, Bray GA. Nicotine increases thermogenesis in brown adipose tissue in rats. Pharmacol Biochem Behav. 1988;29:33-37.
73. Yoshida T, Sakane N, Umekawa T, et al. Nicotine induces uncoupling protein 1 in white adipose tissue of obese mice. Int J Obes Relat Metab Disord. 1999;23:570-575.
74. Hodge AM, Westerman RA, de Courten MP, et al. Is leptin sensitivity the link between smoking cessation and weight gain? Int J Obes Relat Metab Disord. 1997;21:50-53.
75. Li MD, Parker SL, Kane JK. Regulation of feeding-associated peptides and receptors by nicotine. Mol Neurobiol. 2000;22:143-165.
76. Kane JK, Parker SL, Matta SG, et al. Nicotine up-regulates expression of orexin and its receptors in rat brain. Endocrinology. 2000;141:3623-3629.
77. Kalra PS, Dube MG, Xu B, et al. Neuropeptide Y (NPY) Y1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: Evidence for a hypothalamic site for concurrent development of leptin resistance. J Neuroendocrinol. 1998;10:43-49.
78. Kalra SP, Xu B, Dube MG, et al. Leptin and ciliary neurotropic factor (CNTF) inhibit fasting-induced suppression of luteinizing hormone release in rats: Role of neuropeptide Y. Neurosci Lett. 1998;240:45-49.
79. Morley JE, Levine AS, Yim GK, Lowy MT. Opioid modulation of appetite. Neurosci Biobehav Rev. 1983;7:281-305.
80. Levine AS, Billington CJ. Opioids. Are they regulators of feeding? Ann N Y Acad Sci. 1989;575:209-219.
81. Kalra PS, Norlin M, Kalra SP. Neuropeptide Y stimulates beta-endorphin release in the basal hypothalamus: Role of gonadal steroids. Brain Res. 1995;705:353-356.
82. Brugman S, Clegg DJ, Woods SC, Seeley RJ. Combined blockade of both micro- and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein. Endocrinology. 2002;143:4265-4270.
83. Lambert PD, Wilding JP, al-Dokhayel AA, et al. The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat. Brain Res. 1993;629:146-148.